StockVS

NASDAQ · Packaged Foods · USD

Arcadia Biosciences, Inc. (RKDA) Stock Analysis

Arcadia Biosciences, Inc. (RKDA) is a Packaged Foods stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

RKDA

$0.16

+$0.00 (+2.94%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RKDA with… →

RKDA Key Statistics

As of Oct 21, 2026
Trading
Open
$0.15
Previous Close
$0.15
Day's Range
0.14–0.16
52-Week Range
0.11–4.34
Volume
185.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.55
Valuation
Market Cap
$379.45K
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.08
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.55
Financials (FY)
Revenue (FY)
$4.86M−3.71%
Net Income (FY)
−$2.34M
Profit marginThe share of revenue left as profit after all costs and taxes.
−234.53%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
2.41M
1-Year Return
−95.97%
Dividend and dates
Avg Volume
1.87M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, RKDA closed at $0.16, −95.97% over 1 year.

Arcadia Biosciences, Inc. (RKDA) has a market capitalization of $379.45K.

In fiscal 2025, RKDA reported revenue of $4.86M.

RKDA Stock Return by Calendar Year

Arcadia Biosciences, Inc. (RKDA) 10-year return: what $10,000 became

1 year
$10,000 $403
−95.97%
5 years
$10,000 $19
−99.81%
10 years
$10,000 $1
−99.99%

If you had invested $10,000 in Arcadia Biosciences, Inc. (RKDA) 10 years ago, at the close on October 21, 2016, it would have been worth $1 at the close on October 21, 2026: −99.99% in total, −59.60% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−92.05%
2025−66.55%
2024+89.14%
2023−71.13%
2022−73.94%
2021−58.89%
2020−53.83%
2019+72.87%
2018−42.36%
2017−70.11%
2016 (partial year)−61.67%

As of October 21, 2026.

RKDA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$4.86M−$2.34M−48.1%
2024$5.05M−$7.04M−139.5%
2023$4.45M−$13.98M−313.9%
2022$7.42M−$15.38M−207.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.86M$1.76M−$10.00M−$2.34M−48.1%
2024$5.05M$2.08M−$7.61M−$7.04M−139.5%
2023$4.45M$2.28M−$6.02M−$13.98M−313.9%
2022$7.42M$1.32M−$15.23M−$15.38M−207.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

RKDA Valuation vs Packaged Foods Median

Median of 70 stocks
MetricRKDAPackaged Foods medianvs median
P/S ratio0.080.670.1x the median
Profit margin−234.53%2.27%236.8 pts below

Medians across 70 Packaged Foods stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Arcadia Biosciences, Inc. (RKDA) at $379.45K. It is classified in the Packaged Foods industry, within the Consumer Defensive sector. The company reports 8 employees.

RKDA last closed at $0.16 on October 21, 2026. That is $0.00 (+2.94%) against the previous close. The 52-week range on file runs from $0.11 to $4.34. The latest close sits 41.89% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.86M. That is −3.71% against the prior fiscal year, when revenue was $5.05M. The same year closed with a net loss of $2.34M. Profit margin runs at −234.53%. That is 236.8 percentage points below the Packaged Foods median of 2.27%. Trailing earnings per share are −4.55.

Across the 4 fiscal years on file, revenue moves from $7.42M in 2022 to $4.86M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 0.08 times revenue. On price-to-sales that is 0.1 times the Packaged Foods median of 0.67. 70 Packaged Foods companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −95.97%. Across 10 years the annualized return works out at −59.60%. Beta against the wider market is reported at 0.55. Annualized volatility over the trailing 10 years is 149.71%.

Growth & Income

No dividend is on file for RKDA.

The strongest complete calendar year on file is 2024 at +89.14%; the weakest is 2022 at −73.94%. Of the 9 complete calendar years on file, 2 finished higher. So far in 2026 the total return is −92.05%.

Peer Comparison

Arcadia Biosciences, Inc. (RKDA) operates in the Packaged Foods industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Arcadia Biosciences, Inc. RKDA $379.45K —
The Kraft Heinz Company KHC $27.87B —
General Mills, Inc. GIS $17.41B —
Saputo Inc. SAP.TO CA$16.14B 23.7

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Packaged Foods industry average P/E ratio is 14.5x. Arcadia Biosciences, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Packaged Foods Stocks

View all Packaged Foods stocks →

Popular Consumer Defensive Stocks

View all Consumer Defensive stocks →

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Visit website →